Applications for San Francisco (Batch 12) extended AGAIN through September 30th, 2021!

We Are SOSV

The IndieBio program is part of SOSV, which is a US-based venture fund that specializes in early stage investments in categories, namely biotech (IndieBio), Hard tech (HAX), cross-border consumer and enterprise in Asia (MOX and Chinaccelerator) and blockchain (dlab). SOSV’s programs are designed to provide founders intensive, 1:1 help from technical experts and startup mentors in well-equipped facilities develop their products and launch their companies.

1,000 companies and $1 billion AUM

SOSV has a portfolio of more than 1,000 companies and $1 billion in assets under management. SOSV’s founder and managing partner is the serial founder, investor and philanthropist Sean O’Sullivan. SOSV’s programs are highly selective and applications to new cohorts are open throughout the year. Among the top companies in SOSV’s portfolio are NotCo, Perfect Day, Upside Foods (fka Memphis Meats), Yeelight, Opentrons, Shopal, Snapask, BitMEX and API3.

$150K to $500K Investments

All companies in SOSV programs receive early stage (typically pre-seed) investment from SOSV, anywhere from $150K to $500K (depending on the program), and SOSV continues to invest as successful program alumni progress through series seed, series A and beyond. SOSV in June 2021 announced a $100 million Select Fund in order to support the rapidly growing number of SOSV companies advancing to later stage rounds.

Worldwide Presence

SOSV has offices in in Princeton, New Jersey (HQ), San Francisco, New York City, Cork (Ireland), Tokyo, Shenzhen, Shanghai, and Taipei.